Physician profile
Ashley Malone
NPI 1134766991
$13,626.47
in general payments reported to CMS, 2019-2025
34 companies · $3,676 in 2025
The $3,676 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,355 · 2022: $2,559 · 2023: $2,667 · 2024: $3,370 · 2025: $3,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,440 · Education: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,440.13 |
| Education | $272.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,804.33 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,932.25 | 2021-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,133.07 | 2021-2025 | Ofev, Jascayd, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $1,016.91 | 2021-2025 | Glassia, Aralast, Cuvitru |
| Inspire Medical Systems, INC. | $661.49 | 2023-2025 | Inspire |
| Grifols USA, LLC | $643.93 | 2022-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $612.44 | 2021-2024 | Yupelri |
| Electromed, INC. | $601.63 | 2021-2025 | Smartvest |
| Philips North America LLC | $578.43 | 2021-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Axsome Therapeutics, INC. | $571.79 | 2022-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $473.36 | 2024-2025 | |
| Harmony Biosciences LLC | $410.83 | 2025 | |
| Genzyme Corporation | $373.02 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $264.72 | 2022-2023 | Dupixent |
| Verona Pharma, INC. | $196.36 | 2025 | Ohtuvayre |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $160.48 | 2025 | Yupelri |
| Baxter Healthcare | $151.49 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Pulmonx Corporation | $134.50 | 2022-2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Genentech USA, INC. | $123.08 | 2021-2023 | Xolair |
| Teva Pharmaceuticals USA, INC. | $119.60 | 2022 | |
| Amgen INC. | $108.14 | 2022-2024 | Tezspire |
| Janssen Pharmaceuticals, INC | $91.63 | 2021-2022 | |
| Insmed, INC. | $69.19 | 2025 | Brinsupri, Arikayce |
| United Therapeutics Corporation | $68.79 | 2022-2024 | Tyvaso |
| Lilly USA, LLC | $67.69 | 2025 | Zepbound |
| Sanofi-Aventis U.S. LLC | $63.99 | 2024 | |
| Merck Sharp & Dohme LLC | $33.28 | 2021-2023 | |
| Inogen, INC. | $30.43 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.88 | 2023 | Lifevest |
| Zoll Respicardia, INC. | $26.32 | 2025 | Remede System |
| Avadel Cns Pharmaceuticals, LLC | $25.45 | 2025 | Lumryz |
| Ucb, INC. | $19.71 | 2023 | Cimzia |
| Mallinckrodt Hospital Products INC. | $15.37 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.89 | 2023 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.